Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Public Health Genomics and Precision Health Knowledge Base (v5.9)

Note: Javascript is disabled or is not supported by your browser. For this reason, some items on this page will be unavailable. For more information about this message, please visit this page: About CDC.gov.

HuGE Navigator|HuGE Literature Finder|PHGKB

HuGE Literature Finder

Records 1-11

Query Trace: Intestinal Neoplasms and CYP3A4[orginal query]

Relevance of CYP3A420, UGT1A137 and UGT1A1*28 variants in irinotecan-induced severe toxicity. British journal of clinical pharmacology 2018 Mar . Riera P, Salazar J, Virgili A, Tobeña M, Sebio A, Gallano P, Barnadas A, Páez Similar articles in PubMed
Genetic variation in vitamin D-related genes and risk of colorectal cancer in African Americans. Cancer causes & control : CCC 2014 May 25 (5): 561-70. Pibiri Fabio, Kittles Rick A, Sandler Robert S, Keku Temitope O, Kupfer Sonia S, Xicola Rosa M, Llor Xavier, Ellis Nathan Similar articles in PubMed
Modification of menopausal hormone therapy-associated colorectal cancer risk by polymorphisms in sex steroid signaling, metabolism and transport related genes. Endocrine-related cancer 2011 Jun 18 (3): 371-84. Rudolph Anja, Sainz Juan, Hein Rebecca, Hoffmeister Michael, Frank Bernd, Försti Asta, Brenner Hermann, Hemminki Kari, Chang-Claude Jen Similar articles in PubMed
Association of genetic polymorphisms in ESR2, HSD17B1, ABCB1, and SHBG genes with colorectal cancer risk. Endocrine-related cancer 2011 Apr 18 (2): 265-76. Sainz J, Rudolph A, Hein R, Hoffmeister M, Buch S, von Schönfels W, Hampe J, Schafmayer C, Völzke H, Frank B, Brenner H, Försti A, Hemminki K, Chang-Claude Similar articles in PubMed
Pharmacogenetic predictors of adverse events and response to chemotherapy in metastatic colorectal cancer: results from North American Gastrointestinal Intergroup Trial N9741. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010 Jul 28 (20): 3227-33. McLeod Howard L, Sargent Daniel J, Marsh Sharon, Green Erin M, King Cristi R, Fuchs Charles S, Ramanathan Ramesh K, Williamson Stephen K, Findlay Brian P, Thibodeau Stephen N, Grothey Axel, Morton Roscoe F, Goldberg Richard Similar articles in PubMed
A CYP3A4 phenotype-based dosing algorithm for individualized treatment of irinotecan. Clinical cancer research : an official journal of the American Association for Cancer Research 2010 Jan 16 (2): 736-42. van der Bol Jessica M, Mathijssen Ron H J, Creemers Geert-Jan M, Planting André S Th, Loos Walter J, Wiemer Erik A C, Friberg Lena E, Verweij Jaap, Sparreboom Alex, de Jong Floris Similar articles in PubMed
Racial differences in advanced colorectal cancer outcomes and pharmacogenetics: a subgroup analysis of a large randomized clinical trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009 Sep 27 (25): 4109-15. Sanoff Hanna K, Sargent Daniel J, Green Erin M, McLeod Howard L, Goldberg Richard Similar articles in PubMed
Comprehensive pharmacogenetic analysis of irinotecan neutropenia and pharmacokinetics. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009 Jun 27 (16): 2604-14. Innocenti Federico, Kroetz Deanna L, Schuetz Erin, Dolan M Eileen, Ramírez Jacqueline, Relling Mary, Chen Peixian, Das Soma, Rosner Gary L, Ratain Mark Similar articles in PubMed
Genetic variability in CYP3A4 and CYP3A5 in primary liver, gastric and colorectal cancer patients. BMC cancer 2007 7 (1): 118. Gervasini Guillermo, García-Martín Elena, Ladero José M, Pizarro Rosa, Sastre Javier, Martínez Carmen, García Monserrat, Diaz-Rubio Manuel, Agúndez José A Similar articles in PubMed
Polymorphisms in the cytochrome P450 genes CYP1A2, CYP1B1, CYP3A4, CYP3A5, CYP11A1, CYP17A1, CYP19A1 and colorectal cancer risk. BMC cancer 2007 7 (1): 123. Bethke Lara, Webb Emily, Sellick Gabrielle, Rudd Matthew, Penegar Stephen, Withey Laura, Qureshi Mobshra, Houlston Richa Similar articles in PubMed
A comprehensive analysis of phase I and phase II metabolism gene polymorphisms and risk of colorectal cancer. Pharmacogenetics and genomics 2005 Aug 15 (8): 535-46. Landi Stefano, Gemignani Federica, Moreno Victor, Gioia-Patricola Lydie, Chabrier Amélie, Guino Elisabeth, Navarro Matilde, de Oca Javier, Capellà Gabriel, Canzian Federico, Similar articles in PubMed

File Formats Help:

How do I view different file formats (PDF, DOC, PPT, MPEG) on this site?

Page last reviewed:Jul 30, 2019
Page last updated:Aug 22, 2019
Content source:

TOP